Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 2,754 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Hypertension
Interventions: Exercise Program, Combined Exercise and Diet Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 25 Years to 60 Years
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: San Diego, California

Conditions: Alcoholism
Interventions: Transcranial Magnetic Stimulation (rTMS), Sham (SS); Device
Lead sponsor: Nassima Ait-Daoud Tiouririne; Other
Eligibility: 22 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Leukemia, Myelodysplastic Syndromes
Interventions: aldesleukin, filgrastim, natural killer cell (NK) therapy, cyclophosphamide, cyclosporine, fludarabine phosphate, methylprednisolone, mycophenolate mofetil, Umbilical Cord Blood Transplantation (UCBT), Total body irradiation (TBI); Biological · Drug · Procedure + 1 more
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 45 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Interventions: G2-TR intraocular implant containing travoprost, Sham surgery + active-comparator eye drops; Combination Product · Drug
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 590 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Pediatric Obesity, Adolescent Obesity, Weight Loss
Interventions: High-Intensity Interval Training, Moderate-Intensity Continuous Training; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 12 Years to 16 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Henrico, Virginia

Conditions: Physical Activity
Interventions: Walking/Running program, Classroom physical activity break program; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 7 Years to 11 Years
Enrollment: 1,182 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: HTN Educational Video, Visual Echocardiogram Image Clips, Mobile Health and Remote BP monitoring, Post-Acute Care HTN Transition consultation (PACHT-c); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Treatment Resistant Depression
Interventions: Genotyping assays; Genetic
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hearing Loss, Speech and Language Development Delay Due to Hearing Loss
Interventions: Speech-Language Teletherapy; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 0 Months to 27 Months
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: Oakland, California • Palo Alto, California • San Diego, California + 2 more

Conditions: Multiple Myeloma
Interventions: MMprofiler SKY92 gene signature; Device
Lead sponsor: SkylineDx; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 9
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Hackensack, New Jersey + 5 more

Conditions: Hypertension
Interventions: GOALS, Minding GOALS; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 79 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Pain, Opioid Misuse
Interventions: IPGT, Treatment as Usual; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Pain
Interventions: Intermittent Theta Burst Stimulation (iTBS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome
Interventions: Imlifidase, Plasma exchange (PLEX), Cyclophosphamide (CYC), Glucocorticoids; Drug · Procedure
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 6
States / cities: Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 3 more

Conditions: Melanoma (Skin), Skin Cancer, Advanced Melanoma
Interventions: Exercise Program, Diet Program; Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Seattle, Washington

Conditions: Menopause
Interventions: Nitrate-Rich Beetroot Juice, High Intensity Exercise, Moderate Intensity Exercise, Nitrate-Depleted Placebo Beetroot Juice; Dietary Supplement · Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Risky Sexual Behavior, Emotion Regulation, Adolescent Behavior
Interventions: iTRAC-HERO; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 12 Years to 14 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Golden, Colorado

Conditions: Colitis, Ulcerative
Interventions: Vedolizumab; Drug
Lead sponsor: Takeda; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • San Diego, California • Atlanta, Georgia + 8 more

Conditions: Metastatic Prostate Cancer
Interventions: High intensity aerobic and resistance training, Psychosocial support; Behavioral
Lead sponsor: Movember Foundation; Other
Eligibility: 18 Years and older · Male only
Enrollment: 866 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 6
States / cities: Los Angeles, California • San Francisco, California • Denver, Colorado + 3 more

Conditions: HIV Infections
Interventions: ALVAC(2)120(B,MN)GNP (vCP1452), Aldesleukin; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 19 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: Blood Clot, Thrombosis
Interventions: PTT protocol, anti-Xa protocol; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: NASH - Nonalcoholic Steatohepatitis
Interventions: HU6, Placebo; Drug
Lead sponsor: Rivus Pharmaceuticals, Inc.; Industry
Eligibility: 28 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Depression, Depressive Symptoms, Cancer
Interventions: Behavioral Activation Therapy App, Treatment as Usual; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Suicide, Attempted, Suicide Ideation, Suicide, Suicide Prevention
Interventions: Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+), Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 12 Years to 24 Years
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 6
States / cities: St. Petersburg, Florida • Baltimore, Maryland • New York, New York + 2 more

Search by objective public record fields.

Effect of Exercise and Diet on Inflammation in Hypertensive Individuals

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

The Role of High Intensity Interval Training in the Treatment of Adolescent Obesity

Understanding the Impact of School-Based Physical Activity Programs

Targeting of UnControlled Hypertension in Emergency Department

Pharmacogenomics for Antidepressant Guidance and Education

Teletherapy in Children Who Are Deaf and Hard of Hearing

PRospective Multiple Myeloma Impact Study

Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control

Integrative Psychosocial Group Treatment

Accelerated Theta Burst in Chronic Pain: A Biomarker Study

A Study With Imlifidase in Anti-GBM Disease

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females

An Interactive Education Program to Reduce High Risk Behavior in Adolescents Ph II (iTRAC HERO)

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

Inpatient Monitoring of Unfractionated Heparin

Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers

IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings